Literature DB >> 33994055

Neuroprotective effects of aucubin on hydrogen peroxide-induced toxicity in human neuroblastoma SH-SY5Y cells via the Nrf2/HO-1 pathway.

Ying Chun Li1, Jin Cheng Hao1, Bo Shang1, Cheng Zhao2, Li Juan Wang1, Kai Lin Yang1, Xiao Zhou He1, Qian Qian Tian2, Zhao Liang Wang1, Hui Ling Jing3, Yang Li4, Yan Jun Cao5.   

Abstract

BACKGROUND: When redox balance is lost in the brain, oxidative stress can cause serious damage that leads to neuronal loss, in congruence with neurodegenerative diseases. Aucubin (AU) is an iridoid glycoside and that is one of the active constituents of Eucommia ulmoides, has many pharmacological effects such as anti-inflammation, anti-liver fibrosis, and anti-atherosclerosis.
PURPOSE: The present study aimed to evaluate the inhibitory effects of AU on cell oxidative stress against hydrogen peroxide (H2O2)-induced injury in SH-SY5Y cells in vitro.
METHODS: SH-SY5Y cells were simultaneously treated with AU and H2O2 for 24 h. Cell viability was measured by CCK-8. Additionally, mitochondrial membrane depolarization, reactive oxygen species (ROS) generation, and cell apoptosis were measured by flow cytometry.
RESULTS: The results showed that AU can significantly increase the H2O2-induced cell viability and the mitochondrial membrane potential, decrease the ROS generation, malondialdehyde (MDA), and increase glutathione (GSH) contents and the superoxide dismutase (SOD) activity. We also found that H2O2 stimulated the production of nitric oxide (NO), which could be reduced by treatment with AU through inhibiting the inducible nitric oxide synthase (iNOS) protein expression. In H2O2-induced SH-SY5Y cells, the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) content and cell apoptosis were significantly reduced by AU treatment through nuclear factor E2-related factor 2/hemo oxygenase-1 (Nrf2/HO-1) activation, inhibiting the expression of p-NF-κB/NF-κB and down-regulating MAPK and Bcl-2/Bax pathways.
CONCLUSION: These results indicate that AU can reduce inflammation and oxidative stress through the NF-κB, Nrf2/HO-1, and MAPK pathways.
Copyright © 2021. Published by Elsevier GmbH.

Entities:  

Keywords:  Aucubin; Inflammation; Nrf2; Oxidative stress; SH-SY5Y

Mesh:

Substances:

Year:  2021        PMID: 33994055     DOI: 10.1016/j.phymed.2021.153577

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  5 in total

1.  Study on extraction and antibacterial activity of aucubin from Eucommia ulmoides seed-draff waste biomass.

Authors:  Yunhui Liao; Feng Chen; Lujie Xu; Wubliker Dessie; Jiaxing Li; Zuodong Qin
Journal:  Heliyon       Date:  2022-09-26

Review 2.  Research progress on the protective effects of aucubin in neurological diseases.

Authors:  Ping Yang; Qiaoyue Zhang; Hengyan Shen; Xinyu Bai; Ping Liu; Tao Zhang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 3.  Targeting Nrf2-Mediated Oxidative Stress Response in Traumatic Brain Injury: Therapeutic Perspectives of Phytochemicals.

Authors:  An-Guo Wu; Yuan-Yuan Yong; Yi-Ru Pan; Li Zhang; Jian-Ming Wu; Yue Zhang; Yong Tang; Jing Wei; Lu Yu; Betty Yuen-Kwan Law; Chong-Lin Yu; Jian Liu; Cai Lan; Ru-Xiang Xu; Xiao-Gang Zhou; Da-Lian Qin
Journal:  Oxid Med Cell Longev       Date:  2022-04-04       Impact factor: 6.543

4.  Fermented Mentha arvensis administration provides neuroprotection against transient global cerebral ischemia in gerbils and SH-SY5Y cells via downregulation of the MAPK signaling pathway.

Authors:  Md Sadikul Islam; Ha-Young Shin; Yeo-Jin Yoo; Eui-Yong Lee; Ryunhee Kim; Young-Jin Jang; Md Rashedunnabi Akanda; Hyun-Jin Tae; In-Shik Kim; Dongchoon Ahn; Byung-Yong Park
Journal:  BMC Complement Med Ther       Date:  2022-06-25

Review 5.  Targeting Reactive Oxygen Species in Atherosclerosis via Chinese Herbal Medicines.

Authors:  Leyi Zhang; Jiaqin Huang; Danli Zhang; Xiaojing Lei; Yan Ma; Yun Cao; Jingling Chang
Journal:  Oxid Med Cell Longev       Date:  2022-01-10       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.